Back to search

Article

Dolutegravir Inhibits Proliferation and Motility of BT-20 Tumor Cells through Inhibition of Human Endogenous Retrovirus Type K

2022-02-18

Abstract excerpt

Increasing evidence points to the role of endogenous retroviruses (ERVs) in driving cancer cell proliferation. The purpose of this study was to explore the possibility of repurposing antiretroviral agents to inhibit ERVs as a new approach in cancer treatment. We found that an integrase strand-transfer inhibitor, dolutegravir (DTG), effectively inhibited the proliferation of multiple cancer cell lines and its antip...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ba055688-deab-5b18-9963-434e586ad94d
DOI
10.20944/preprints202202.0223.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dolutegravir Inhibits Proliferation and Motility of BT-20 Tumor Cells through Inhibition of Human Endogenous Retrovirus Type KDOI 10.20944/preprints202202.0223.v1
Select a neighboring publication to make it the new centre.